John Stroehlein
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Gottumukkala Subba Raju (6 shared papers)Yinghong Wang (5 shared papers)Hamzah Abu‐Sbeih (5 shared papers)Phillip J. Lum (4 shared papers)Wei Qiao (2 shared papers)Emily Mao (2 shared papers)Noman Ali (2 shared papers)Adi K. Diab (2 shared papers)
- Journals
- Inflammatory Bowel Diseases (2 papers)Endoscopy (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)International Journal of Oncology (1 paper)The American Journal of Gastroenterology (1 paper)
- Partner nations
- United States
In The Last Decade
John Stroehlein
18 papers receiving 852 citations
Peers
Comparison fields: 5 of 48
- Oncology 564
- Hepatology 51
- Immunology 64
- Gastroenterology 20
- Cancer Research 29
Countries citing papers authored by John Stroehlein
This map shows the geographic impact of John Stroehlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Stroehlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Stroehlein more than expected).
Fields of papers citing papers by John Stroehlein
This network shows the impact of papers produced by John Stroehlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Stroehlein. The network helps show where John Stroehlein may publish in the future.
Co-authors
The 25 scholars most cited alongside John Stroehlein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 206 | |
| 2 | 2018 | 203 | |
| 3 | 2014 | 100 | |
| 4 | 1981 | 76 | |
| 5 | Pustular psoriasis induced by infliximab. | 2004 | 71 |
| 6 | 2018 | 69 | |
| 7 | 2013 | 65 | |
| 8 | 1983 | 24 | |
| 9 | 2019 | 20 | |
| 10 | 2020 | 15 | |
| 11 | Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer. | 1983 | 12 |
| 12 | 1983 | 8 | |
| 13 | 1983 | 5 | |
| 14 | 2019 | 5 | |
| 15 | 1983 | 4 | |
| 16 | 2012 | 4 | |
| 17 | 1994 | 3 | |
| 18 | 2019 | 1 | |
| 19 | 2019 | 0 |
About John Stroehlein
John Stroehlein is a scholar working on Oncology, Surgery, Speech and Hearing, Gastroenterology and Hepatology, having authored 19 papers that have together received 891 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Screening and Detection (2 papers), Esophageal and GI Pathology (2 papers), Cancer therapeutics and mechanisms (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Gastrointestinal motility and disorders (1 paper). The work is most often cited by research in Oncology (564 citations), Hepatology (51 citations), Immunology (64 citations), Gastroenterology (20 citations) and Cancer Research (29 citations). John Stroehlein has collaborated with scholars based in United States. Frequent co-authors include Gottumukkala Subba Raju, Yinghong Wang, Hamzah Abu‐Sbeih, Phillip J. Lum, Wei Qiao, Emily Mao, Noman Ali, Adi K. Diab, Gladis A. Shuttlesworth and Faisal S. Ali. Their work appears in journals such as Inflammatory Bowel Diseases, Endoscopy, Journal for ImmunoTherapy of Cancer, International Journal of Oncology and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.